Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TILDRAKIZUMAB-ASMN vs TIOCONAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TILDRAKIZUMAB-ASMN vs TIOCONAZOLE: Safety Overview

Metric TILDRAKIZUMAB-ASMN TIOCONAZOLE
Total FAERS Reports 1,621 1,434
Deaths Reported 92 14
Death Rate 5.7% 1.0%
Hospitalizations 69 19
Average Patient Age 63.8 yrs 43.6 yrs
% Female Patients 53.8% 99.8%
FDA Approval Date N/A Feb 11, 1997
Manufacturer N/A H E B
Route N/A VAGINAL
Marketing Status Prescription Discontinued